Evidence map›Paper›PMID 36238683›Full record

ArticleFrontiers in cell and developmental biology2022

Effect of

James Kealey, Heiko Düssmann, Irene Llorente-Folch, Natalia Niewidok, Manuela Salvucci, Jochen H M Prehn, Beatrice D'Orsi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Current computer-aided drug design · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

James KealeyDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Heiko DüssmannDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Irene Llorente-FolchDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Natalia NiewidokDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Manuela SalvucciDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Jochen H M PrehnDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Beatrice D'OrsiDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Royal College of Surgeons in Ireland · IEUniversidad Rey Juan Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic reprogramming is a hallmark of cancer. Somatic mutations in genes involved in oncogenic signaling pathways, including

Indexed as

bioenergeticsCancer Metabolismcolorectal cancermetabolic stressOxPhos

Identifiers

PMID36238683
PMCPMC9550869
OpenAlexW4297394786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.